case presentation out put 2

Upload: angelica-duque

Post on 03-Apr-2018

230 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 Case Presentation Out Put 2

    1/28

    University of La Salette

    College of NursingSantiago City

    Philippines

    BronchopnuemoniaLucas Paguila Medical Clinic Hospital

    August 07, 2012

    Prepared by:

    BSN-3A Bracket C

  • 7/29/2019 Case Presentation Out Put 2

    2/28

    Introduction

    Bronchopneumonia is an illness of lung, which is caused by different organism likebacteria, viruses, and fungi and characterized by acute inflammation of the walls of the

    bronchioles. It is also known as pneumonia. It is common in women and causes to the 6% deaths.Streptococcus pneumoniae (pneumococcus) and Mycoplasma pneumonia both are the common

    bacterium, which causes bronchopneumonia in the adults and children.

    CAUSESBacteria

    Virus

    Bacterial pneumonias tend to be the most serious and, in adults, the most common causeof pneumonia. The most common pneumonia-causing bacterium in adults is Streptococcus

    pneumonia (pneumococcus).

    RISK FACTOR

    ElderlyHospitalizationImmobilization

    Immune Deficiency

    Long Term Illness

    Smoking

  • 7/29/2019 Case Presentation Out Put 2

    3/28

    Lung abscess is an acute or chronic infection of the lung, marked by a localized collection

    of pus, inflammation, and destruction of tissue. Lung abscess is the end result of a number ofdifferent disease processes ranging from fungal and bacterial infections to cancer.

    DIAGNOSTIC TEST

    1. ABG is a test done to measure how much oxygen and carbon dioxide is in your blood. It also

    looks at the acidity (pH) of the blood. Usually, blood gases look at blood from an artery. In rarer

    cases, blood from a vein may be used.

    2. CBC

    Complete blood count (CBC) test measures the following:

    The number of red blood cells (RBCs)The number of white blood cells (WBCs)

    The total amount of hemoglobin in the blood

    The fraction of the blood composed of red blood cells (hematocrit)

    The mean corpuscular volume (MCV) -- the size of the red blood cellsCBC also includes information about the red blood cells that is calculated from the other

    measurements:

    MCH (mean corpuscular hemoglobin)

  • 7/29/2019 Case Presentation Out Put 2

    4/28

    Anatomy and Physiology

    Respiratory System:

    - Consists of the external nose, the nasal cavity, the Pharynx, the Larynx, the Trachea, theBronchi and the Lungs.

    Function:

    Gas exchange Filters inspired air Voice production Olfaction Regulate blood pH

    Upper Respiratory Tract: (Nose-Larynx)

    Nose -the external opening of the Respiratory System-Consist of External nares /nostrils and Nasal Cavities

    RESPONSIBILITY:-Rich supply of capillaries warm the inspired air

    -Olfactory mucosa

    -Respiratory Mucosa

  • 7/29/2019 Case Presentation Out Put 2

    5/28

    -Supported by a framework of nine pieces of cartilage (Three individual pieces

    and three cartilage pairs ) that area held in place by ligaments and muscles

    *Trachea (Wind pipe)-Is a membranous tube consists of connective tissue and smooth Muscle,

    Reinforced with 16-20 C shaped pieces of cartilage

    -Adult: about 1.4-1.6 cm in diameter and about 10-11 cm long.

    *Bronchi

    -The trachea divides the left and right main (primary) bronchi each of which

    connects to the lung.-The left main bronchus is more horizontal than the right main bronchus because

    it displaced by the Heart. Foreign objects that enter the trachea usually logged in

    the right main Bronchus; because it is more it is more vertical than the left mainBronchus and therefore more indirect line with the trachea. The trachea is lined

    with psuedostratified ciliated columnar epithelium and are supported by C

    shaped pieces of cartilage.

    *Lungs

    -Are the principal organs of respiration.

    -Each lung is cone shaped, with its base resting on the diaphragm and its apexextending superiorly to a point about 2.5 centimeters above the clavicle.

    -The lung has three lobes: the superior, middle and inferior lobe.

    -Includes the Bronchioles, and the alveoli.

  • 7/29/2019 Case Presentation Out Put 2

    6/28

    Demographic Data

    Name: Pt. Honey Pooh

    Gender: Female

    Age: 4 y/oBirthdate: December 20, 2007

    Birthplace: Ipil, Echague Isabela

    Address: Paddad, Alicia, IsabelaReligion: Roman Catholic

    Nationality: FilipinoEthnicity: IlocanoAdmission

    Date: July 31, 2012

    Time: 4:30 pm

    Attending Physician: Dra. PaguilaChief Complaint: cough for 3 days, dyspnea, and fever for 1 day

    Initial Vital Signs:Temp: 38. 9 C

    PR: 148bpm

    RR: 48 cpm

  • 7/29/2019 Case Presentation Out Put 2

    7/28

    Nursing History

    History of Present Illness

    According to the patient's mother, the patient was hospitalized at Lucas-Paguila with a

    diagnosis of bronchopneumonia on June 26, 2012. Three days prior to admission, the patient

    experienced cough & dyspnea. On July 31, 2012 the patient had a fever in the morning so theyadmitted her at Lucas-Paguila Medical hospital at 4:40PM.

    History of Past Illness

    According to the patients mother, this is the 4th

    time that her daughter has been admitted

    to the hospital. The first time that the patient was admitted to the hospital was at the age of 9

    months; the patient had a chief complaint of cough and fever. At the age of 1 year and 2 months,the patient was admitted to Lucas-Paguila due to loose bowel movement. She has completed all

    her vaccines. The patient has no known food allergies.

    Family Health History

    The patient has a family health history of asthma, diabetes mellitus, and hypertension.

  • 7/29/2019 Case Presentation Out Put 2

    8/28

    Gordon's Functional Health Pattern

    PRIOR TO ADMISSION DURING ADMISSION

    Health perception - Health

    Management Pattern

    According to the mother,

    the patient has a healthy

    body.

    The child is unaware of

    her condition.

    Nutritional - Metabolic

    pattern

    According to the patients

    mother, the patient eatsthree times a day. She eats

    fatty foods but also eatsvegetables and fruits likesquash and apple. She

    drinks 1 glass of water a

    day and 5-10 7-ounce

    bottles of milk a day. Shealso drinks soft drinks.

    During admission, the

    patient does not eatregularly. She only drinks

    1/2 glass of water in themorning. During one shift,the patient consumed 1 1/2

    bottles of milk.

    Elimination Pattern According to the patients

    mother, the patientdefecates daily every

    noon. The patient urinates4-5 times a day.

    The patient did not

    defecate since the first dayof her admission. During

    the shift, the patienturinated twice.

    Activity - Exercise Pattern According to the patientsmother, the patient wakes

    The patient was dependenton her mother for her

  • 7/29/2019 Case Presentation Out Put 2

    9/28

    Coping Stress Tolerance

    Pattern

    According to the mother,

    the patient has a close

    relationship with themother. The mother would

    help solve all the problemsthat the patient may have.

    The relationship between

    the mother and the patient

    is still strong. The patienttalks with the mother for

    any needs.

    Value - Belief Pattern The patient is a RomanCatholic. She was baptized

    at Our Lady of Atochia

    Church when she was a

    year old. According to themother, the patient and

    mother prays together

    every day.

    The mother and patientprays together.

  • 7/29/2019 Case Presentation Out Put 2

    10/28

    1st

    Physical Assessment

    Date: August 01, 2012

    Time: 1:00PM

    Vital Signs:

    Temp: 38. 9 CPR: 148 bpm

    RR: 48 cpm

    General Appearance: Received patient lying on bed with an ongoing D5 .03 NaCl 500ml regulated at

    30ugtts/min hooked at right arm, patent and infusing well.

    Mood: responsive, alert, awake

    Behavior: acting with appropriate behavior

  • 7/29/2019 Case Presentation Out Put 2

    11/28

    Physical Assessment

    AREA ASSESSED METHODS FINDINGS INTERPRETATION

    1. SKINCOLOR

    TEXTURE

    TEMPERATURE

    MOISTURE

    TURGOR

    INSPECTION

    INSPECTION

    ANDPALPATION

    PALPATION

    PALPATION

    PALPATION

    Light brown

    skin color

    Smooth

    Normally

    warm

    Smooth

    Snacks back

    to previous

    state

  • 7/29/2019 Case Presentation Out Put 2

    12/28

    COLOR

    PUPIL (PERRLA)

    INSPECTION

    INSPECTION

    Pink red

    Responds to

    pen light

    NORMAL

    NORMAL

    6. EXTERNALAUDITORY CANAL

    HEARING INSPECTION Hearing

    equally in

    both ears

    NORMAL

    7. NOSESYMMETRY

    COLOR

    INSPECTION

    INSPECTION

    Symmetrical

    Same color as

    the face

    NORMAL

    NORMAL

    8. LIPS AND MOUTH

  • 7/29/2019 Case Presentation Out Put 2

    13/28

    12.UPPEREXTREMITIES

    SYMMETRY

    ROM

    INSPECTION

    INSPECTION

    Symmetrical

    (+) Full range

    of motion

    NORMAL

    NORMAL

    13.LOWEREXTREMITIES

    SIZE

    SYMMETRY

    ROM

    INSPECTION

    INSPECTION

    INSPECTION

    Equal in size

    Symmetrical

    (+) Full range

    of motion

    NORMAL

    NORMAL

    NORMAL

  • 7/29/2019 Case Presentation Out Put 2

    14/28

    Laboratory ResultsDate: August 31,2012, 12:05pm

    CBC RESULTS NORMAL INTERPRETATION

    RBCHct

    Hgb

    WBC

    4.430.35

    128

    10.9

    4-60.4-0.54

    130-180

    5-10

    NORMALNORMAL

    NORMAL

    NORMAL

    DIFFERENTIAL

    LymphocytesMonocytes 0.240.06 0.25-.350.03-0.14 NORMAL

    BLOOD INDICES

    MCV (mean cell volume)

    MCH (mean corpuscularhemoglobin)MCHC (Mean Cell

    Hemoglobin Concentration)

    79.5

    28.9

    36.4

    86-110

    26-38

    31-37

    NORMAL

    NORMAL

  • 7/29/2019 Case Presentation Out Put 2

    15/28

    Pathophysiology

    Predisposing Factors Etiologic Agent Precipitating Factors- Age - Streptococcus pneumonia - immunocompromise

    - Sex - Staphylococcus aureus - underlying lung disease- Escherichia coli - alcoholism

    -Mycoplasma pneumonia - malnutrition

    - altered consciousness

    Aspiration of microorganism

    Adherence to alveolar

    macrophages; exposure of cell

    wall components

  • 7/29/2019 Case Presentation Out Put 2

    16/28

    Pathophysiology

    Aspiration of oropharyngeal secretions is the most common route of lower respiratorytract infection; thus the nasopharynx and oropharynx constitute the first line of defense for most

    infectious agents. Another route of infection is through the inhalation of microorganisms thathave been released into the air when an infected individual coughs, sneezes, or talks, or form

    aerosolized water, such as that from contaminated respiratory therapy equipment. In healthy

    individuals, pathogens that reach the lungs are expelled or held in check by mechanisms of self-

    defense (First line: Physical, Mechanical, and Biochemical Barriers, Second line: InflammatoryResponse, Immunity, cough reflex, mucociliary clearance). If a microorganism gets past the

    upper airway defense mechanisms, the next line of defense is the alveolar macrophage. Thisphagocyte is capable of removing most infectious agents without setting off significantinflammatory or immune responses. However, if the microorganism is virulent or present in large

    enough numbers, it can overwhelm the alveolar macrophage and result in a full-scale activation

    of the bodys defense mechanism, including the release of multiple inflammatory mediators,

    cellular infiltration, and immune activation. These inflammatory mediators and immunecomplexes can damage bronchial mucous membranes and alveolocapillary membranes, causing

    the acini (cluster of cells that resembles a many-lobed "berry"; the berry-shaped termination of

    an exocrine gland, where the secretion is produced, is acinar in form, as is the alveolar saccontaining multiple alveoli in the lungs) and terminal bronchioles to fill with infectious debris

    and exudate. In addition, some microorganisms release toxins from their cell walls that can cause

    further lung damage. The accumulation of exudate in the acinus leads to dyspnea and to V/Q

    mismatching and hypoxemia. The immune response includes complement activation and theproduction of antibodies which are crucial for opsonizing the encapsulated bacterium

  • 7/29/2019 Case Presentation Out Put 2

    17/28

    Course in the Ward

    Date Doctors Order

    July 31, 2012

    4:35pm

    - Admit to ROC- V/S q 4- For CBC- D5 0.3 NaCl 500 ml at 30 ggts/min- Paracetamol 120 mg q 4h for T- 38 C-

    Hydrocortisone 25 mg IV q 8- Aerosol with salbutamol- Cefuroxime 250mg IV q 6 ANST- Oxygen at 2-36 for dyspnea- Refer for any signs and symptoms

  • 7/29/2019 Case Presentation Out Put 2

    18/28

    Nursing Care Plan

    Date: August 01, 2012

    ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

    Subjective: none

    Objective:

    RestlessnessProductive cough

    (+) Rhonchi on rightlower lobe

    Temp: 38. 9 CPR: 148 bpm

    RR: 48 cpm

    Risk for

    ineffective airwayclearance r/taccumulation of

    tracheobronchialsecretions

    After 3-4 hours of

    nursing intervention,the patient will be ableto maintain patent

    airway clearance AEBreduction of congestion

    with breath soundsclear

    Monitor V/s Elevate HOB and

    encourage frequent

    positioning

    Auscultate breathsounds and assessair movement

    Keep back dry andloosen clothingand teach deep

    breathing andcoughing exercises

    Instruct the motherto increase fluid

    intake

    Provide adequaterest periods

    Givebronchodilators as

    ordered Administer oxygen

    therapy and othermedications as

    ordered

    For baseline data Ventilation to different

    lung segment

    To ascertain status andnote progress

    To promote comfortand adequateventilation and promote

    pulmonary hygiene

    To liquefy secretions

    Rest will preventfatigue and decrease

    oxygen demands

    To clear airway whensecretions are blocking

    the airway To increase oxygen

    saturation

    After 3-4 hours of

    nursing intervention,the patientmaintained a patent

    airway AEB areduction of

    congestion withclear breath sounds.

    GOAL MET

  • 7/29/2019 Case Presentation Out Put 2

    19/28

    Date: August 01, 2012

    ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

    Subjective: none

    Objective:

    Restlessness(+) Rhonchi on right

    lower lobe

    Temp: 38. 9 CPR: 148 bpm

    RR: 48 cpm

    Risk for impaired

    Gas Exchange r/tinflammation of

    airways and

    accumulation ofsputum affecting

    O2 and O2transport

    After 4-5 hours of nursing

    intervention, the patient willdemonstrate improvement

    in gas exchange AEB a

    decrease in respiratory rateto normal (22-34 cpm)

    Monitor V/S Observe color of skin,

    mucous and nail beds

    Elevate HOB andencourage frequent

    position changes Encourage deep

    breathing andcoughing exercises

    Keep back dry andloosen clothing

    Provide adequate restperiods

    Instruct mother toincrease fluid intake

    of the child

    Administer oxygentherapy as ordered

    For baseline data To note in any

    changes of the

    status of your gasexchange

    To facilitate thediaphragm

    To promote goodpulmonary

    hygiene

    To promotecomfort and

    adequate

    ventilation Rest will preventfatigue anddecrease oxygen

    demands formetabolic

    demands

    To liquefysecretions

    To increaseoxygen saturation

    After 4-5 hours of

    nursing intervention, thepatients respiratory rate

    decreased to 42 cpm

    GOAL NOT MET

  • 7/29/2019 Case Presentation Out Put 2

    20/28

    Date: August 01, 2012

    ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

    Subjective: none

    Objective:

    Warm to touch

    Body weaknessLack of appetite

    V/S:

    Temp: 38. 9 C

    PR: 148 bpmRR: 48 cpm

    Hyperthermia r/tinflammatory process

    After 30 minutes to 1hour of nursing

    intervention, the

    temperature of the pt.will decrease from

    38.9C to at least 37.5C

    Establish rapport Monitor V/s Perform TSB

    Promote surfacecooling by means

    of undressing

    Encourage fluidintake

    Maintain patentairway and

    provide blanket

    Maintain bed restand adequate rest

    periods

    Administerantipyretics asordered

    To gain trust For baseline data TSB promotes

    heat loss throughevaporation and

    conduction To provide

    comfort and

    prevent chills

    To supportcirculating

    volume and tissueperfusion

    To promotepatients safety

    and to avoidchills

    To reducemetabolic

    demands andoxygen

    consumption

    To decreasecirculating

    pyrogens

    After 30 minutes to 1hour nursing

    intervention, the

    temperature decreasedfrom 38.9 C to 37.8 C

    GOAL PARTIALLYMET

  • 7/29/2019 Case Presentation Out Put 2

    21/28

    Date: August 01, 2012ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

    Subjective:

    Objective:

    (+) Rhonchi in rightlower lobeProductive cough

    RestlessnessCough

    Tachypnea

    V/S:Temp: 38. 9 C

    PR: 148 bpmRR: 48 cpm

    Risk for infection r/t

    suppressed inflammatoryresponse

    At the end of the shift,

    the patient will be freefrom possible spread of

    infection.

    Monitor V/S Encourage the

    mother to

    perform goodhand-washingtechniques

    Encourageadequate rest

    periods

    Stress theimportance ofincreasing the

    childs nutritionalintake

    Instruct mother toprovide goodhygiene for thechild

    Instruct mother toprovide adequate

    safe drinkingmilk/water for the

    child

    Instruct mother tokeep the childwarm and to

    provide a blanket

    To establishbaseline data

    To reduce spreador acquisition of

    infection

    To enhance fastrecovery and

    regain strength

    Good nutritionintake canstrengthen the

    bodys immunesystem

    To prevent entryof microbes

    To prevent GIdisturbance

    To avoid chillsand to prevent thechild from having

    a fever

    At the end of the shift,

    the patient has been freefrom possible spread of

    infection.

    GOAL MET.

  • 7/29/2019 Case Presentation Out Put 2

    22/28

    Date: August 01, 2012

    ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

    Subjective:

    Objective:

    Lack of appetite

    Lack of interest to foodoffered

    Risk for imbalancednutrition r/t decrease

    nutrient absorption

    At the end of theshift, the patient

    will consume at

    least 65% of thefood offered

    Monitor vital signs Assess for difficulty of

    swallowing and the

    ability to swallow

    Encourage familymembers to prepare

    food of patientspreferences- develop

    meal plan with thepatient

    Ask the mother to jointhe child during meal

    time

    Instruct client to avoidcaffeinated beverages

    Promote adequate andtimely fluid intake bylimiting fluids 30

    minutes prior to meal

    Encourage small butfrequent feedings

    Instruct the client to eata bland diet, low in

    roughage, avoiding hot,spicy, or very acidic

    foods

    To have baseline data Can be factors that

    can affect ingestion

    and causative ofaltered nutrition

    To maintain adequatecaloric intake

    To meet thenutritional needs of

    the client

    It stimulates gastricmotility

    To reduce possibilityof early satiety

    May reduce fatigueand thus enhanceintake while

    preventing gastricdistention

    This reduces thestress on the

    gastrointestinal tract

    The patient only ate 50%of foods offered.

    GOAL NOT MET.

  • 7/29/2019 Case Presentation Out Put 2

    23/28

    Drug Study

    DRUG NAME ACTION INDICATION CONTRAINDICATION SIDE EFFECTS NSG.

    CONSIDERATION

    Generic Name:

    Hydrocortisone

    Classification:Adrenal Cortical steroid

    CorticosteroidGlucocorticoid

    Therapeutic Class:Hormone

    Enters target cells and

    binds to cytoplasmicreceptor; initiates manycomplex reactions that are

    responsible for itsanti-inflammatory,

    immunosuppressive(glucocorticoid), and salt-

    retaining

    (mineralocorticoid)actions. Some actions

    maybe undesirable,depending on drug use

    -Replacement therapy in

    adrenal corticalinsufficiency-Allergic states

    Severeorincapacitating allergic

    conditions-Hematologic disorders

    -Ulcerative colitis

    -Allergy to any component

    of the drug-Fungal infections-Amebiasis

    -Hepatitis B-Vaccinia or varicella

    -Antibiotic-Resistant infections

    -Immunosuppression

    CNS:

    Vertigo, headache,paresthesias, insomnia,seizures, psychosis

    CV:Hypotension,shock,HPN

    and heart failuresecondary to fluid

    retention,

    thromboembolism,thrombophlebitis, fat

    embolism, cardiacarrhythmias

    Dermatologic:Thin, fragile skin,

    petechiae, ecchymosis,

    purpura, striae,

    subcutaneous fat atrophy

    EENT:Cataracts, glaucoma,increased IOP

    Endocrine:Amenorrhea, irregular

    mens, growth retardation,decreased carbohydrate

    tolerance and DM,cushingoid state, HPA

    suppression systemic,

    Before

    - Assessforcontraindications.- Assess body weight,

    skincolor, V/S,urinalysis, serum

    electrolytes, X-rays, CBC.- Arrange for increased

    dosage when patient is

    subject to unusual stress.- Do not give live

    vaccines withimmunosuppressive

    dosesofhydrocortisone.- Observe the 15 rightsof drug administration.

    During- Give daily before 9amto mimic normal peak

    diurnalcorticosteroidlevels.

    - Space multiple dosesevenly throughout the

    day.- Use minimal doses for

    minimal duration tominimize adverse

    effects.

  • 7/29/2019 Case Presentation Out Put 2

    24/28

    hyperglycemia

    GI:Peptic or esophagealulcer, pancreatitis,

    abdominal distention,nausea, vomiting,

    increased appetite and

    weight gainHematologic:

    Na and fluid retention,

    hypocalcemia, increasedblood sugar, increased

    serum cholesterol,decreased T3 and T4

    levels

    Hypersensitivity:Anaphylactoidorhypersensitivity

    reactions

    Musculoskeletal:Muscle weakness, steroidmyopathy and loss of

    muscle mass,osteoporosis, spontaneous

    fractures

    Other:Immunosuppression,aggravation or masking

    ofinfections, impairedwound healing

    - Do not give IMinjections if patient has

    thrombocytopenicpurpura.

    - Taper doses whendiscontinuing high-dose

    orlong-term therapy.

    After

    - Monitor client for at

    least 30minutes.- Educate client on the

    sideeffects ofthemedication and what to

    expect.- Instruct client to report

    pain at injection site.- Instruct client to take

    drug exactly as

    prescribed.- Dispose ofusedmaterials properly.

    - Document that drughas been given

  • 7/29/2019 Case Presentation Out Put 2

    25/28

    DRUG NAME ACTION INDICATION CONTRAINDICATION SIDE EFFECTS NSG.CONSIDERATION

    Generic Name:

    Cefuroxime

    Classification: antibioticCephalosporin

    Dosage: 250 mg PO bid

    Route: oral

    Bactericidal: inhibits

    synthesis of bacterial cellwall, causing cell death.

    Acute bacterial maxillary

    sinusitis caused bystreptococcus pyrogens.

    Lower respiratoryinfections caused by

    streptococcus

    pneumonia, H. influenza

    Contraindicated with

    allergy to cephalosporinsand penicillins.

    Use cautiously with renalfailure, lactation,

    pregnancy

    CNS: headache,

    dizziness, lethargy,paresthiasis.

    GI: nausea and

    vomiting, diarrhea,anorexia, abdominal

    pain, flatulence.

    HEMATOLOGIC:bone marrow depression(WBC, decreased

    platelets, decreasehematocrit.)

    HYPERSENSITIVITY: Ranging rush to fever to

    anaphylaxis: serum

    sickness reaction.

    Assessment:

    History: hepatic andrenal impairment,

    lactation, pregnancy.

    Physical: Skin Status,culture of affected area.

    Oral Drug:

    Give oral drug with food

    to decrease GI upset andenhance absorption.

    Discontinue ifhypersensitivity

    occurred.

    Parenteral Drug:

    Report severe diarrhea,difficulty of breathing,unusual tiredness or

    fatigue, pain at injection

    site

  • 7/29/2019 Case Presentation Out Put 2

    26/28

    DRUG NAME ACTION INDICATION CONTRAINDICATION SIDE EFFECTS NSG.

    CONSIDERATION

    Generic

    Name: SalbutamolSulfate AlbuterolSulfate

    Brand

    Name: AccuNeb,Airomir, Proventil,

    Proventil HFA, ProventilRepetabs, Ventolin,

    Ventolin HFA, VentolinObstetric Injection,

    Ventolin Rotacaps,

    Volmax, VoSpire ER

    Available

    Forms: Capsules forinhalation: 200mcgInjection: 1 mg /ml Solution forinhalation: 0.083%,

    0.5%, 0.63 mg / ml, 1.25mg / 3 ml Syrup: 2 mg /5 ml Tablets: 2 mg, 4mg Tablets (extended-release): 4 mg, 8 mg

    Relaxes bronchial,

    uterine, and vascularsmooth muscle by

    stimulating beta2

    receptors.

    * To prevent or treat

    bronchospasm in patientswith reversible

    obstructive airway

    disease * To prevent exercise-

    induced bronchospasm * Acute asthma * Symptom relief duringmaintenance therapy of

    asthma and otherconditions with

    reversible or irreversibleairways obstruction

    (including COPD and

    bronchitis)

    * Contraindicated in

    patients hypersensitive to

    drug or its ingredients. * Use with caution in

    patients with CV

    disorders (includingcoronary insufficiency

    and hypertension),hyperthyroidism,

    diabetes mellitus, and

    those who are unusuallyresponsive to

    adrenergics * Use extended-releasetablets cautiously in

    patients with GI

    narrowing.

    . CNS: tremor,

    nervousness, dizziness,insomnia, headache,

    hyperactivity, weakness,

    CNS stimulation,

    malaise CV: tachycardia,

    palpitations,

    hypertension EENT: dry and irritatednose and throat with

    inhaled form, nasalcongestion, epistaxis,

    hoarseness GI: heartburn, nausea,vomiting, anorexia,altered taste, increased

    appetite

    * Drug may

    decrease sensitivityof spirometry used

    for diagnosis of

    asthma.* When switching

    from regular toextended-release

    tablets, keep inmind that a regular

    2 mg tablet every 6hours is equivalent

    to an extended-release 4 mg tablet

    every 12 hours.* Syrup may etaken by children as

    young as age 2; itcontains no alcohol

    or sugar.* Rarely, erythema

    multiforme orStevens-Johnson

    Syndrome has beenlinked to use of

    syrup in children.

  • 7/29/2019 Case Presentation Out Put 2

    27/28

  • 7/29/2019 Case Presentation Out Put 2

    28/28

    DRUG NAME ACTION INDICATION CONTRAINDICATION SIDE EFFECTS NSG.CONSIDERATION

    Generic Name:

    Paracetamol

    Brand Name:

    Classification:

    Analgesic, Anti pyretics

    Dose: 1ampFrequency: for PRN

    meds q 4-6 hours

    Route: oral

    Indicated in conditions

    like Ear pain, Headache,Malaise, Migraine, mild

    to moderate pain, Pain,

    Post-vaccine reaction,Short bowel syndrome,

    Toothache.

    Paracetamol exhibits

    analgesic action byperipheral blockage pain

    impulse generation. It

    produces antipyresis byinhibiting the

    hypothalamic heat-regulating center. Its

    weak anti-inflammatoryactivity is related to

    inhibition ofprostaglandin synthesis

    in the CNS

    Contraindicated in

    conditions like

    hypersensitivity

    Nausea, allergic reaction,

    skin rashes, acute renaltubular, necrosis.

    Potentially fatal: Liverdamage

    If sensitivity reaction

    occurs, discontinue useof paracetamol

    If pain persist more than10 days and arthritic and

    rheumatic conditionaffecting children,

    immediately consult

    physician.